| 1 |
Matsumoto Y，Niimi N，Kohyama K. Development of a new DNA vaccine for Alzheimer disease targeting a wide range of abeta species and amyloidogenic peptides［J］.PLoS One，2013，8（9）：e75203.
|
| 2 |
Bloom GS.Amyloid-beta and tau： the trigger and bullet in Alzheimer disease pathogenesis［J］. JAMA Neurol，2014，71（4）：505-508.
|
| 3 |
Janus C，Pearson J，McLaurin J，et al.A beta peptide immunization reduces behavioural impairment and plaques in a model ofAlzheimer's disease［J］.Nature，2000，408（6815）：979-982.
|
| 4 |
Ballatore C，Lee VM，Trojanowski JQ.Tau-mediated neurodegeneration in Alzheimer's disease and related disorders［J］. Nat Rev Neurosci，2007，8（9）：663-672.
|
| 5 |
Gonsalves D，Jovanovic K，Da Costa Dias B，et al. Global Alzheimer Research Summit： basic and clinical research： present and future Alzheimer research［J］.Prion，2012，6（1）：7-10.
|
| 6 |
Ferri CP，Prince M，Brayne C，et al.Global prevalence of dementia：a Delphi consensus study［J］.Lancet，2005，366（9503）：2112-2117.
|
| 7 |
McKhann G，Drachman D，Folstein M，et al. Clinical diagnosis of Alzheimer's disease： report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease［J］.Neurology，1984，34（7）：939-944.
|
| 8 |
Dubois B，Feldman HH，Jacova C，et al. Research criteria for the diagnosis of Alzheimer's disease： revising the NINCDS-ADRDA criteria［J］.Lancet Neurol，2007，6（8）：734-746.
|
| 9 |
Malek-Ahmadi M，Davis K，Belden CM，et al. Comparative analysis of the Alzheimer questionnaire （AQ） with the CDR sum of boxes，MoCA，and MMSE［J］. Alzheimer Dis Assoc Disord，2014，28（3）：2 9 6-2 9 8.
|
| 10 |
van de Pol LA，Hensel A，Barkhof F，et al. Hippocampal atrophy in Alzheimer disease：age matters［J］.Neurology，2006，66（2）：236-238.
|
| 11 |
Davatzikos C，Xu F，An Y，et al. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults： the SPARE-AD index［J］.Brain，2009，132（Pt 8）：2026-2035.
|
| 12 |
Dickerson BC. Diagnostic tests for Alzheimer disease： Judicious use can be helpful in clinical practice［J］. Neurol Clin Pract，2012，2（2）：1 5 4-1 5 7.
|
| 13 |
Forsberg A，Engler H，Almkvist O，et al. PET imaging of amyloid deposition in patients with mild cognitive impairment［J］. Neurobiol Aging，2008，29（10）：1456-1465.
|
| 14 |
Basun H，Bogdanovic N，Ingelsson M，et al. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease［J］.Arch Neurol，2008，65（4）：499-505.
|
| 15 |
Lleo A，Berezovska O，Growdon JH，et al. Clinical，pathological，and biochemical spectrum of Alzheimer disease associated with PS-1 mutations［J］.Am J Geriatr Psychiatry，2004，12（2）：146-156.
|
| 16 |
Malkki H. Alzheimer disease： Effects of the APOE epsilon4 allele on brain development［J］.Nat Rev Neurol，2014，10（1）：4.
|
| 17 |
Lambert MP，Barlow AK，Chromy BA，et al. Diffusible，nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins［J］. Proc Natl Acad Sci U SA，1998，95（11）：6448-6453.
|
| 18 |
Tapiola T，Alafuzoff I，Herukka SK，et al.Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain［J］.Arch Neurol，2009，66（3）：382-389.
|
| 19 |
Mehta PD，Pirttila T，Patrick BA，et al.Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease［J］.Neurosci Lett，2001，304（1-2）：102-106.
|
| 20 |
Wallin AK，Blennow K，Andreasen N，et al. CSF biomarkers for Alzheimer's Disease： levels of beta-amyloid，tau，phosphorylated tau relate to clinical symptoms and survival［J］. Dement Geriatr Cogn Disord，2006，21（3）：131-138.
|
| 21 |
de la Monte SM，Wands JR. Neurodegeneration changes in primary central nervous system neurons transfected with the Alzheimerassociated neuronal thread protein gene［J］. Cell Mol Life Sci，2001，58（5-6）：844-849.
|
| 22 |
Munzar M，Levy S，Rush R，et al. Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease［J］.Neurol Clin Neurophysiol，2002，2002（1）：2-8.
|
| 23 |
Ghanbari H，Ghanbari K，Beheshti I，et al. Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker［J］. Journal of clinical laboratory analysis，1998，12（5）：285-288.
|
| 24 |
Bartel DP. MicroRNAs： genomics，biogenesis，mechanism，and function［J］.Cell，2004，116（2）：281-297.
|
| 25 |
Ambros V. The functions of animal microRNAs［J］. Nature，2004，431（7006）：350-355.
|
| 26 |
Ji R，Cheng Y，Yue J，et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation［J］.Circ Res，2007，100（11）：1579-1 5 8 8.
|
| 27 |
Lukiw WJ. Micro-RNA speciation in fetal，adult and Alzheimer's disease hippocampus［J］.Neuroreport，2007，18（3）：297-300.
|
| 28 |
Mitchell PS，Parkin RK，Kroh EM，et al. Circulating microRNAs as stable blood-based markers for cancer detection［J］. Proceed Nat Acad Sci，2008，105（30）：10513-10518.
|
| 29 |
Saugstad JA. MicroRNAs as effectors of brain function with roles in ischemia and injury，neuroprotection，and neurodegeneration［J］. J Cerebral Blood Flow Metabol，2010，30（9）：1564-1576.
|
| 30 |
Lim LP，Lau NC，Garrett-Engele P，et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs［J］.Nature，2005，433（7027）：769-773.
|
| 31 |
Wang WX，Huang Q，Hu Y，et al.Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex： white matter versus gray matter［J］.Acta Neuropathol，2011，121（2）：193-205.
|
| 32 |
Hebert SS，Horre K，Nicolai L，et al. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression［J］. Neurobiol Dis，2009，33（3）：422-428.
|
| 33 |
Delay C，Calon F，Mathews P，et al.Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function［J］.Mol Neurodegener，2011，6：70.
|
| 34 |
Wang WX，Rajeev BW，Stromberg AJ，et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1［J］. J Neurosci，2008，28（5）：1213-1223.
|
| 35 |
Hébert SS，Horre K，Nicolai L，et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression［J］. Proc Natl Acad Sci U S A，2008，105（17）：6415-6420.
|
| 36 |
Long JM，Ray B，Lahiri DK. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1（BACE1）in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects［J］.J Biol Chem，2014，289（8）：5184-5198.
|
| 37 |
Boissonneault V，Plante Ⅰ，Rivest S，et al. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1［J］.J Biol Chem，2009，284（4）：1971-1981.
|
| 38 |
Sala Frigerio C，Lau P，Salta E，et al. Reduced expression of hsamiR-27a-3p in CSF of patients with Alzheimer disease［J］. Neurology，2013，81（24）：2103-2106.
|
| 39 |
Banzhaf-Strathmann J，Benito E，May S，et al. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease［J］.EMBO J，2014，33（15）：1667-1680.
|
| 40 |
Lukiw WJ，Zhao Y，Cui JG. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells［J］. J Biol Chem，2008，283（46）：3 1 3 1 5-3 1 3 2 2.
|
| 41 |
Guedes JR，Custodia CM，Silva RJ，et al. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model［J］.Hum Mol Genet，2014，23（23）：6286-6301.
|
| 42 |
Wang X，Liu P，Zhu H，et al. miR-34a，a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease，inhibits bc12 translation［J］.Brain Res Bull，2009，80（4-5）：268-273.
|
| 43 |
Lee ST，Chu K，Jung KH，et al. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model［J］. Ann Neurol，2012，72（2）：269-277.
|
| 44 |
Bekris LM，Lutz F，Montine TJ，et al. MicroRNA in Alzheimer's disease： an exploratory study in brain，cerebrospinal fluid and plasma［J］.Biomarkers，2013，18（5）：455-466.
|
| 45 |
Müller M，Kuiperij HB，Claassen JA，et al.MicroRNAs in Alzheimer's disease： differential expression in hippocampus and cell-free cerebrospinal fluid［J］.Neurobiol Aging，2014，35（1）：152-158.
|
| 46 |
Kiko T，Nakagawa K，Tsuduki T，et al. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease［J］. J Alzheimer's Dis，2014，39（2）：253-259.
|
| 47 |
Liu CG，Song J，Zhang YQ，et al. MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease［J］.Mol Med Rep，2014，10（5）：2395-2400.
|
| 48 |
Liu CG，Wang JL，Li L，et al. MicroRNA-384 regulates both amyloid precursor protein and beta-secretase expression and is a potential biomarker for Alzheimer's disease［J］. Int J Mol Med，2014，34（1）：1 6 0-1 6 6.
|
| 49 |
Galimberti D，Villa C，Fenoglio C，et al. Circulating miRNAs as potential biomarkers in Alzheimer's disease［J］. J Alzheimer Dis，2014，42（4）：1261-1267.
|
| 50 |
Bhatnagar S，Chertkow H，Schipper HM，et al. Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma［J］.Front Mol Neurosci，2014，7：2.
|
| 51 |
Tan L，Yu JT，Tan MS，et al. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease［J］.JAlzheimers Dis，2014，40（4）：1017-1027.
|
| 52 |
Leidinger P，Backes C，Deutscher S，et al.A blood based 12-miRNA signature ofAlzheimer disease patients［J］.Genome Biol，2013，14（7）：R78.
|